- Home
- HUBB vs BNTX Comparison
HUBB vs BNTX Comparison
Compare HUBB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- BNTX
- Stock Information
- Founded
- HUBB 1888
- BNTX 2008
- Country
- HUBB United States
- BNTX Germany
- Employees
- HUBB N/A
- BNTX N/A
- Industry
- HUBB Industrial Machinery/Components
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUBB Technology
- BNTX Health Care
- Exchange
- HUBB Nasdaq
- BNTX Nasdaq
- Market Cap
- HUBB 20.9B
- BNTX 25.0B
- IPO Year
- HUBB N/A
- BNTX 2019
- Fundamental
- Price
- HUBB $414.84
- BNTX $109.95
- Analyst Decision
- HUBB Hold
- BNTX Strong Buy
- Analyst Count
- HUBB 8
- BNTX 18
- Target Price
- HUBB $455.50
- BNTX $141.55
- AVG Volume (30 Days)
- HUBB 488.9K
- BNTX 771.1K
- Earning Date
- HUBB 07-29-2025
- BNTX 08-04-2025
- Dividend Yield
- HUBB 1.27%
- BNTX N/A
- EPS Growth
- HUBB 10.31
- BNTX N/A
- EPS
- HUBB 14.79
- BNTX N/A
- Revenue
- HUBB $5,594,600,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- HUBB $7.60
- BNTX N/A
- Revenue Next Year
- HUBB $5.93
- BNTX $10.68
- P/E Ratio
- HUBB $28.04
- BNTX N/A
- Revenue Growth
- HUBB 1.97
- BNTX 0.61
- 52 Week Low
- HUBB $299.43
- BNTX $76.53
- 52 Week High
- HUBB $481.35
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- HUBB 67.36
- BNTX 57.74
- Support Level
- HUBB $402.04
- BNTX $105.35
- Resistance Level
- HUBB $414.31
- BNTX $109.68
- Average True Range (ATR)
- HUBB 7.41
- BNTX 2.56
- MACD
- HUBB 1.19
- BNTX 0.05
- Stochastic Oscillator
- HUBB 86.82
- BNTX 87.00
About HUBB Hubbell Inc
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.